Functional consequences of dopaminergic degeneration in Parkinson's disease.
Tedroff
J M
JM
Department of Neuroscience, Neurology, University Hospital, Uppsala, Sweden.
D000222:Adaptation, Physiological / Q000502:physiology; D001921:Brain / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology*; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D009410:Nerve Degeneration / Q000503:physiopathology*; D010300:Parkinson Disease / Q000503:physiopathology*; D017448:Receptors, Dopamine D2 / Q000502:physiology
D017448:Receptors, Dopamine D2; D007980:Levodopa; D004298:Dopamine